Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 21,305,266 $ 16,966,168
Accounts receivable 3,223 0
Prepaid expenses 585,313 267,518
Other current assets 525,013 322,593
Total Current Assets 22,418,815 17,556,279
Property and equipment, net 3,265,025 2,981,225
Operating lease right-of-use assets 234,095 381,483
Intangible assets, net 328,703 372,305
Total Assets 26,246,638 21,291,292
Current Liabilities    
Accounts payable 1,414,266 627,253
Accrued liabilities 2,333,253 2,168,588
Management and directors' fees payable 10,499 21,979
Current portion of long-term debt 692,715 647,569
Current portion of finance lease liabilities 54,276 97,946
Current portion of operating lease liabilities 163,516 257,244
Current portion of grant repayable 39,321 39,295
Total Current Liabilities 4,707,846 3,859,874
Long-term debt, net of current portion 1,914,207 2,195,278
Finance lease liabilities, net of current portion 580,787 607,708
Operating lease liabilities, net of current portion 78,495 131,875
Grant repayable, net of current portion 302,106 297,991
Total Liabilities 7,583,441 7,092,726
STOCKHOLDERS' EQUITY    
Common Stock, Authorized: 100,000,000 shares of common stock, at $0.001 par value Issued and outstanding: 46,659,554 shares and 41,125,303 shares, respectively 46,660 41,125
Additional paid-in capital 118,915,549 103,853,627
Accumulated other comprehensive income 425,276 125,670
Accumulated deficit (100,708,942) (89,821,856)
Total VolitionRx Limited Stockholders' Equity 18,678,543 14,198,566
Non-controlling interest (15,346) 0
Total Stockholders' Equity 18,663,197 14,198,566
Total Liabilities and Stockholders' Equity $ 26,246,638 $ 21,291,292